Apoptosis and angiogenesis: Two promising tumor markers in breast cancer

Anticancer Research

Volumn 16, Issue 4 B, 1996, Pages 2233-2239

  Wu, Jianxin ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Apoptosis; Breast cancer

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR MARKER;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER THERAPY; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENETICS; HOMEOSTASIS; HUMAN; METASTASIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; TUMOR GROWTH;

APOPTOSIS; BREAST NEOPLASMS; FEMALE; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0029809910     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Boring CC, Squires TS, Tong T: Cancer statistics, 1993. CA Cancer J Clin 43: 726, 1993.
2. Baum M, Ziv Y, Colletta A: Prospects for the chemoprevention of breast cancer. In: British medical bulletin: Breast cancer new approaches. (Stewart HJ, Anderson TJ, Forrest APM, eds), London, Churchill Livingstone, 1991, pp 493-503.
3. Folkman J: Tumor angiogenesis: Therapeutic implications. N Engl J Med 285: 1182-1186, 1971.
4. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
5. Clarke PG and Clarke S: Historic apoptosis, Nature 378: 230, 1995.
6. Bardon S, Vignon F, Montcourrier P and Rochefort H: Steroid receptor-mediated cytotoxicity of an antiestrogen and an antiprogestin in breast cancer cells. Cancer Res 47: 1441-1448, 1987.
7. Hertig AT: Angiogenesis in the early human chorion and in the primary placenta of the Macaque monkey. Contrib Embryol 25: 37-81, 1935.
8. Folkman J, Cole P and Zimmerman S: Tumor behavior in isolated perfused organs: in vitro growth and metastasis of biopsy material in rabbit thyroid and canine intenstinal segment. Ann Surg 164: 491-502, 1966.
9. Gasparini G: Biological and clinical role of angiogenesis in breast cancer. Breast Cancer Res Treat 36: 103-107, 1995.
10. Horak E, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepniewaska K, and Harris AL: Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. Lancet 340: 1120-1124, 1992.
11. Visscher DW, Smilanetz S, Drozodowicz S and Wykes SM: Prognostic significance of image morphometric microvessel enumeration in breast cancarcinoma. Analytical Quant Cytolol Histol 15: 88-92, 1993.
12. Toi M, Kashitani J and Tominaga T: Tumor angiogenesis is an independent prognostic indicator of primary breast canarcinoma. Int J Cancer 55: 371-374, 1993.
13. Gasparini G, Weidner N, Bevilacqua P, Maluta S, Dalla Palma P, Cafto O, Barbareschi M, Boracchi P, Marubini E, Pozza F: Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant to prognostic markers in node-negative breast carcinoma. J Clin Oncol 12: 454-466, 1994.
14. Gasparini G, Pozza F and Harris AL: Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J Natl Cancer Inst 85: 1206-1219, 1993.
15. Wyllie AH: Apoptosis and the regulation of cell numbers in normal and neoplastic tissues: an overview. Cancer Metastasis Rev 11: 95-103, 1992.
16. Marx J: Cell death studies yield cancer clues. Science 259: 760-761, 1993.
17. Walker NI, Bennett RE and Kerr JFR: Cell death by apoptosis during involution of the lactating breast in mice and rat. Am J Anat 185: 19-32, 1989.
18. Geske FJ, Bemis LT, Schedin PJ and Strange R: Function evaluation of genes associated with apoptotic cell death of mammary epithelium. Proc Annu Meet Am Assoc Cancer Res 35: 19, 1994.
19. Allan DJ, Howell A, Roberts SA, Williams GT, Watson RJ, Coyne JD, Clarke RB, Laidlaw IJ and Potten CS: Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast. J Pathol 167: 25-32, 1992.
20. Tomei LD, Kanter P and Wenner CE: Inhibition of radiation-induced apoptosis in vitro by tumor promoters. Biochem Biophys Res Commun 155: 324-331, 1988.
21. Meyn RF, Stphens LC, Mason KA and Medina D: Apoptosis in the normal and irradiated murine mammary gland. Proc Annu Meet Am Assoc Cancer Res 35: 19, 1994.
22. Wu J, Burton SA, Lu DM, Li PC and Dowset M: Analysis of serum reproductive hormone levels in premenpausal women at increased high risk for breast cancer. Breast Cancer Res Treat 37: 99, 1996.
23. Dowsett M, Johnston SRD, Newby J, Golding M, Sacks N, and Smith IE: Mechanisms of hormone response: a role for apoptosis. Endocrine-Related Cancer 2: 3-11, 1995.
24. Kyprianou N, English HF, Davidson NE and Isaacs JT: Progammed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 51: 162-166, 1991.
25. Warri AM, Huovinen RL, Laine AM, Martikainen PM and Harkonen PL: Apoptosis in torimefene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer Inst 85: 1412-1418, 1993.
26. Dowsett M: (unpublished data).
27. Huovinen R, Warri A and Collan Y: Mitotic activity, apoptosis and TRPM-2 mRNA expression in DMBA-induced rat mammary carcinoma treated with anti-estrogen toremifene. Int J Cancer 55: 685-691, 1993.
28. Ellis PA, Detre S, Burton SA, Salter J, Johnston SRD, Smith IE and Dowsett M: Changes in proliferation, apoptosis, and bcl-2 in breast cancer specimens following neoadjuvant chemotherapy. Breast Cancer Res Treat 37: 36, 1996.
29. Folkman J, Klagsburn M: Angiogenic factors. Science 235: 442-447, 1987.
30. Folkman J, Watson K, Ingber D, Hanahan D: Induction of angiogenesis during the transition from hypelplasia to neoplasia. Nature 339: 58-61, 1989.
31. Brem S, CotranR and FolkmanJ: Tumor angiogenesis: aquantitative method for histologic grading. J Natl Cancer Inst 48: 347-356, 1972.
32. Klagshrun M, Knighton D, Folkman J: Tumor angiogenesis activity in cells grown in tissue culture. Cancer Res 36: 110-4, 1976.
33. Folkman J: Angiogenesis and its inhibitors. Import Adv Oncol 42-62, 1985.
34. Czubayko F, Schulte AM, Missner SC, Hsieh SS, Colley KJ and Wellstein A: Molecular and pharmacologic targeting of angiogenesis factors- the example of pleiotrophin. Breast Cancer Res Treat 36: 157-168, 1995.
35. Weidner N: Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36: 169-180, 1995.
36. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
37. Gasparini G and Harris AL: Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 13: 765-782, 1995.
38. FoLkman J: Angiogenesis and breast cancer. J Clin Oncol 3: 441-443, 1994.
39. Berm SD, Jensen HM, Gullino PM: Angiogenesis as a marker of preneoplastic lesions of the human breast. Cancer 41: 239-244, 1978.
40. Fidler JI and Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 185-188, 1994.
41. Berm SS, Medina D: Angiogenesis: A marker for neoplaistic transformation of mammary papillary hyperplasia. Science 195: 880-881, 1977.
42. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S and Gasparini G: Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84: 1875-1887, 1992.
43. Folkman J: The role of angiogenesis in tumor growth, Semin Cancer Biol 3: 65-71, 1992.
44. Folkman J: The influence of angiogenesis research on management of patients with breast cancer. Breast Cancer Res Treat 36: 109-118, 1995.
45. O' Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH and Folkman J: Angiogenesis: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328, 1994.
46. Choi ME and Ballermann BJ: Inhibition of capillary morphgenesis and associated apoptosis by dominant negative mutant transforming frowth factor-ß receptors. J Biol Chem 270: 21144-21150, 1995.
47. Holmgren L, O'Reilly MS and Folkman J: Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Medicine 1: 149-153, 1995.
48. Murray C: Tumor dormancy: not so sleepy after all. Nature Medicine 1: 117-118, 1995.
49. Powis G, Hill SR, Frew TJ and Sherrill KW: Inhibitors of phospholipid intracellular signaling as antiproliferative agents. Med Res Rev 15: 121-138, 1995.
50. Wang TTY and Phang JM: Effect of estrogen on the apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res 55: 2487-2489, 1995.
51. Kerr JFR, Winterford CM and Harmon BV: Apoptosis: its significance in cancer and cancer therapy. Cancer 73: 2013-2026, 1994.
52. Sierra A, Lloveras B, Castellsague X, Moreno L, Garcia-Ramirez M and Fabra A: Bcl-2 expression is associated with lymph node metastasis in human ductal breast cancinoma. Int J Cancer 60: 54-60, 1995.
53. Johnston SRD, MacLennan KA, Sacks NPM, Salter J, Smith IE and Dowsett M: Modulation of Bcl-2 and Ki-67 expression in oestrogen receptor-positive human breast cancer by tamoxifen. Eur J Cancer 30: 1663-1669, 1994.
54. Bicknell R, Harris AL. Novel growth regulatory factors and tumour angiogenesis. Eur J Cancer 27: 781-785, 1991.
55. Harris AL: What does Bcl-2 mean in solid tumors - friend or foe? Ann Oncol 5: 388-390, 1994.
56. Wu J and Chang Y: Tumour suppressor gene p53 and breast cancer (review). Cancer Research on Prevention and Treatment 11: 155-158, 1995.
57. Symonds H, Krall L, Remington L, Saenz-Robles M, Lowe S, Jacks T and Van Dyke T: p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78: 703-711, 1994.
58. Wagner AJ, Small MB and Hay N: Myc-mediated apoptosis is blocked by ectopic expression of bcl-2. Mol Cell Biol 13: 2432-2440, 1993.
59. Armstrong DK, Kaufmann SH, Ottaviano YL, Furuya Y, Buckley JA, Isaacs JT, Davidson NE: Epidermal growth factor-mediated apoptosis of MDA-MB-468 human breast cancer cells. Cancer Res 54: 5280-5283, 1994.
60. Warri AM, Huovinen RL, Laine AM, Martikainen PM and Harkonen PL: Apoptosis in torimefene-induced growth inhibition of human breast cancer cells in vivo and in vitro. J Natl Cancer Inst 85: 1412-1418, 1993.
61. WAF/CiP1 induces growth arrest, giant cell formation and apoptosis in human breast carcinoma cell lines. Oncogene 11: 1899-1905, 1995.
62. WAF/CIP1 in breast epithelial cels. Cancer Res 55: 4520-4524, 1995.
63. Folkman J: Toward a new understanding of vascular proliferative disease in children. Pediatrics 74: 850-6, 1984.
64. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1: 27-31, 1995.
65. Ethier SP: Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst 87: 964-973, 1995.
66. Li VW, Folkerth RD, Watanabe H, Yu C, Rupnick M, Barnes P, Scott RM, Black PM, Sallan SE, Folkman J: Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344: 82-6, 1994.
67. Toi M, Hoshima S, Takayanagi T, Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85: 1045-1049, 1994.
68. Hlatky L, Tsionou C, Hahnfeldt P, and Coleman CN: Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induces vascular endothelial growth factor up-regulation and protein expression. Cancer Res 54: 6083-6086, 1994.
69. Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter KC, Harris AL: Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study. J Pathol 176: 183- 190, 1995.
70. Nguyen M, Watanabe H, Budson AE, Richie JP, Hayes DF and Folkman J: Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. J Natl Cancer Inst 86: 356-361, 1994.
71. Bochner BH, Nichols PW, Esrig D, Klmajian D, Skinner DG, Jones P, Cote RJ: Relationship between p53 and tumor angiogenesis in invasive transitional cell carcinoma (TCC) of the bladder. Proc Am Assoc Cance Res 36: 91, 1995.
72. Dowsett M, Johnson SRD, Detre S, Salter J, Humphries S, Saccani-Jotti G, Smith IE, MacLennan K and Trott P: Cytological evaluation of biological variable in breast cancer patients undergoing primary medical treatment. In. Sex hormone and antihormones in endocrine dependent pathology: basic and clinical aspects (Motta M, Serio M, eds), Milan, Elsevier Science B. V., 1994, pp329-336.
73. Lipponen P, Aaltomaa S, Kosma VM and Syrjanen K: Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 30: 2068-2073, 1994.
74. Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius VM, Niskanen E, Nordling S and Reed JC: Reduced expression of proapoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 55: 4471-4478, 1995.
75. McCulloch P, Choy A and Martin L: Association between tumor angiogenesis and tumor cell shedding into effluent venous blood during breast cancer surgery. Lancet 346: 1334-1335, 1995.
76. Weider N, Semple J, Welch W and Folkman J: Tumor angiogenesis correlates with metastasis invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
77. Toi M, Inada K, Suzuki H and Tominaga T: Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Breast Cancer Res Treat 36: 193-204, 1995.
78. Gasparini G, Bevilacqua P, Boracchi P, Maluta S, Pozza F, Barharcschi M, Palma PD, Mezzetti M and Harris AL: Prognostic value of p53 expression in early stage breast carcinoma compared with tumor angiogenesis, epidermal growth factor receptor, c-erbB-2, cathepsin D, DNA ploidy. paramenters of cell kinetics and conventional features. Int J Oncol 4: 155-162, 1994.
79. Barbareschi M, Gasparini G, Morelli L, Forti S and Dalla Palma P: Novel methods for the determination of the angiogenic activity of human tumors. Breast Cancer Res Treat 36: 181-192, 1995.
80. Harris AL, Zhang H, Moghaddam A, Fox S, Scott P, Pattison A, Gatter K, Stratfort I and Bicknell R: Breast cancer angiogenesis - new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting. Breast Cancer Res Treat 38: 97- 108, 1996.